Apoptosis, ANUP, Chromogranin A, PGP 9.5, Endothelins and VEGF in Acquired Heart Diseases: Review of Literature

1. Aase K, VonEuler G, Li X et al. Vascular Endothelial Growth Factor-B-Deficient Mice Display an Atrial Conduction Defect // Circulation, 2001; 104: 358.-36410.1161/01.CIR.104.3.358Search in Google Scholar

2. Abbote A, Biondi-Zoccai GGL, Bussani R. et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure // J Am Coll Cardiol, 2003; 41(5): 753.-76010.1016/S0735-1097(02)02959-5Search in Google Scholar

3. Accornero F, VanBerlo JH, Benard MJ. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism // Circ Res, 2011; 109(3): 272.-28010.1161/CIRCRESAHA.111.240820Search in Google Scholar

4. Agapitov AV, Haynes WG. Role of endothelin in cardiovascular disease // J Renin Angiotensin Aldosterone Syst, 2002; 3 (1): 1-15Search in Google Scholar

5. Ahmed A, Johansson O, Folan-Curran J. Distribution of PGP 9.5, TH, NPY, SP and CGRP immunoreactive nerves in the rat and guinea pig atrioventricular valves and chordae // J Anat, 1997; 191: 547.-56010.1046/j.1469-7580.1997.19140547.xSearch in Google Scholar

6. Baba HA, Takeda A, Takeda N et al. Left Ventricular Assist Device: Morphological, Molecular and Genetic Changes After Mechanical Support // Ostadal B., Nagano M., Dhalla N.S. Genes and Cardiovascular Function / London: Springer, 2011; 235-240Search in Google Scholar

7. Bellamo D, Headrick JP, Silins GU et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia //Circ Res, 2000; 86: 29.-3510.1161/01.RES.86.2.e29Search in Google Scholar

8. Bhavani SS, Parshuram JS, Nitish RM et al. Chromogranin A: a novel susceptibility gene for essential hypertension // Cell Mol Life Sci, 2010; 67: 861-874Search in Google Scholar

9. Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease // Cardiovasc Res, 2007; 76: 8-18Search in Google Scholar

10. Bold AJ, Borenstein HB, Veress AJ et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats // J Am Soc Nephrol, 2001; 13: 403.-40910.1681/ASN.V122403Search in Google Scholar

11. Brooks ES, Rodeheffer RJ, Reeder GS et al. Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation // J Am Coll Cardiol, 1990; 16(7): 1589.-159310.1016/0735-1097(90)90305-9Search in Google Scholar

12. Burninston JG, Saini A, Tan L et al. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo // J Mol Cell Cardiol, 2005; 39(2): 395.-39910.1016/j.yjmcc.2005.04.00115907929Search in Google Scholar

13. Bussani R, Abbate A, Biondi-Zoccai GGL et al. Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans // J Clin Pathol, 2003; 56: 672.-67610.1136/jcp.56.9.672177005812944550Search in Google Scholar

14. Canty JM. Coronary Blood Flow and Myocardial Ischemia // Bonow RO, Mann DL, Zipes DP. Braunwald`s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012; 1049.-1075Search in Google Scholar

15. Cea LB. Natriuretic peptide family: new aspects // Curr Med Chem Cardiovasc Hematol Agents, 2005; 3(2): 87.-9810.2174/156801605354430915853696Search in Google Scholar

16. Ceconi C, Ferrari R, Bachetti T. et al. Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality // Eur Heart J, 2002; 23: 967-974Search in Google Scholar

17. Chalajour F, Treede H, Gehling UM et al. Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve // Exp Cell Res, 2007; 313: 2326.-233510.1016/j.yexcr.2007.02.033Search in Google Scholar

18. Chen P, Chen L, Cao J et al. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death // Cardiovasc Res, 2001; 50: 409.-41610.1016/S0008-6363(00)00308-4Search in Google Scholar

19. Chenn H.H., Burnett J.C. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system // J Cardiovasc Pharmaco, 1998; 32(3): 22.-28Search in Google Scholar

20. Chow LTC, Chow SSM, Anderson R.H et al. Autonomic Innervation of the Human Cardiac Conduction System: Changes from Infancy to Senility An Immunohistochemicaland Histochemical Analysis // Anat Rec, 2001; 264: 169-182Search in Google Scholar

21. Chow LT, Chow SS, Anderson RH et al. The innervation of the human myocardium at birth // J Anat, 1995; 187: 107.-114Search in Google Scholar

22. Chow LT, Chow SS, Anderson RH et al. The innervation of the human cardiac conduction system at birth // Brit Heart J, 1993; 69: 430.-43510.1136/hrt.69.5.43010251077686024Search in Google Scholar

23. Crick SJ, Wharton J, Sheppard MN et al. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study // Circulation, 1994; 89: 1697.-170810.1161/01.CIR.89.4.1697Search in Google Scholar

24. Crippa L, Bianci M, Colombo B et al. A new chromogranin A- dependent angiogenic switch activated by trombin // Blood, 2013; 121 (2): 392.-40210.1182/blood-2012-05-430314354411823190532Search in Google Scholar

25. Dashkevich A, Lemstrom KB, Nykanem AI. VEGF Receptor Signaling in the Cardiac Lymphatic System // Karunamuni G. The Cardiac Lymphatic System. -New York: Springer, 2013- 125.-14410.1007/978-1-4614-6774-8_9Search in Google Scholar

26. Davenport AP, Oreilly G, Molenaar P. Human Endothelin Receptors Characterized Using Reverse- Transcriptase-Polymerase Chain Reaction, in Situ Hybridisation and Subtype Selective Ligands BQ123 and BQ3020: Evidence for Expression of Etb Receptors in Human Vascular Smooth Muscle // J Cardiovasc Pharmacol, 1993; 22(8): 22.-2510.1097/00005344-199322008-000087509950Search in Google Scholar

27. Empel VPM., Bertrand ATA., Hofstra L et al. Myocyte apoptosis in heart failure // Cardiovasc Res, 2005; 67: 21 - 29Search in Google Scholar

28. Ferrera N. Molecular and viological properties of vascular endothelial growth factor // J Mol Med, 1999; 77: 527.-54310.1007/s00109990001910494799Search in Google Scholar

29. Ferrera N., Davis-Smyth T. The biology of vascular endothelial growth factor // Endocrine Reviews, 1997; 18(1): 4.-2510.1210/edrv.18.1.02879034784Search in Google Scholar

30. Fischer D, Rossa S, Landmesser U et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death // Eur Heart J, 2005; 26 (1): 65-69Search in Google Scholar

31. Forssmann WG, Richter R, Meyer M. The endocrine heart and natriuretic peptides: histochemistry, cell biology, and functional aspects of the renal urodilation system // Histochem Cell Biol, 1998; 110:335.-35710.1007/s0041800502959792413Search in Google Scholar

32. Fujitami Y, Ninomiya H, Okada T et al. Supression of Endothelin-1-induced Mitogenic Responses of Human Aortic Smooth Muscle Cells by Interleukin-1β // J Clin Invest, 1995; 95: 2474.-248210.1172/JCI1179482959287769093Search in Google Scholar

33. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation // J Cell Bio, 1992; 119(3): 493.-50110.1083/jcb.119.3.49322896651400587Search in Google Scholar

34. Genest J, Libby P. Lipoprotein Disorders in Cardiovascular Disease // Bonow RO, Mann DL, Zipes DP. Braunwald`s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012; 975.-995Search in Google Scholar

35. Gerber HP, Dixit V, Ferrera N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells // J Biol Chem, 1998; 273 (21): 13313.-1331610.1074/jbc.273.21.133139582377Search in Google Scholar

36. Glattard E, Angelone T, Strub JM, et al. Characterization of natural vasostatin-containing peptides in rat heart // The FEBS Journal, 2006; 273: 3311-3321Search in Google Scholar

37. Goetze JP, Alehagen U, Flyvbjerg A et al. Making sense of chromogranin A in heart disease // Lancet Diabetes Endocrinol, 2013; 1 (1): 7-8Search in Google Scholar

38. Goetze JP, Hilsted LM, Rehfeldand JF et al. Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure // Endocr Connect, 2014; 3: 47-56Search in Google Scholar

39. Gottieb RA, Burleson KO, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes // J Clin Invest, 1994; 94: 1621.-162810.1172/JCI1175042953227929838Search in Google Scholar

40. Hasan W. Autonomic cardiac innervation. Development and adult plasticity //Organogenesis, 2013; 9(3): 176.-19310.4161/org.24892389658923872607Search in Google Scholar

41. Heatwole LC. TUNEL Assay for Apoptotic Cells // Javois L.C. Methods in Molecular Biology: Immunocytochemical Methods and Protocols -2nd ed.- New Jersey: Humana Press, 1999; 141.-148Search in Google Scholar

42. Hengartner MO, Horvitz HR. Programmed cell death in Caenorhabditis elegans // Curr Opin Genetics Dev, 1994; 4: 581-586Search in Google Scholar

43. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy // J Investig Med, 2005; 53(7): 366.-370.10.2310/6650.2005.5370916297364Search in Google Scholar

44. Ishikawa Y, Akasaka Y, Ishii T et al. Sequential changes in localisation of repair-related proteins (heat shock protein 70, ubiquitin and vascular endothelial growth factor) in the different changes of myocardial infarction // Histopathology, 2000; 37: 546.-55410.1046/j.1365-2559.2000.00994.x11122437Search in Google Scholar

45. Kabara M, Tatsumi T, Kambayashi D et al. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model // J Cardiovasc Pharmacol, 2003; 41: 880.-88910.1097/00005344-200306000-0000812775965Search in Google Scholar

46. Kadzerski RM, Yanagisawa M. Endothelin system: The double edged sword in health and disease // Annu Rev Pharmacol Toxicol, 2001; 41: 851.-876 10.1146/annurev.pharmtox.41.1.85111264479Search in Google Scholar

47. Karu I, Starkopf J, Zilmer K et al. Growth Factors Serum Levels in Coronary Artery Disease Patients Scheduled for Bypass Surgery: Perioperative Dynamics and Comparisons with Healthy Volunteers // http://dx.doi.org/10.1155/2013/985404 (10.06.2014)10.1155/2013/985404374590823984427Search in Google Scholar

48. Kawai K, Quin F, Shite J et al. Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy // Am J Physiol Heart Circ Physiol, 2004; 287(3): 1003.-101210.1152/ajpheart.00797.200315105169Search in Google Scholar

49. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics // Br J Cancer, 1972; 26: 239.-25710.1038/bjc.1972.3320086504561027Search in Google Scholar

50. Krown KA, Page MT, Nguyen C et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death // J Clin Invest, 1996; 98(12): 2854.-286510.1172/JCI1191145077538981934Search in Google Scholar

51. Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides // Br J Pharmacol, 2012; 166 (2): 522-531Search in Google Scholar

52. Laslop A, Doblinger D, Weiss U. Proteolytic Processing of Chromogranins // Helle B., Aunis D. Chromogranins. Functional and Clinical Aspects. USA: Kluwer Academic Publishers, 2002; 155.-16510.1007/0-306-46837-9_1211192577Search in Google Scholar

53. Lee J, Gray A, Yuan J et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 // Cell Biol, 1996; 93: 1988.-199210.1073/pnas.93.5.1988398968700872Search in Google Scholar

54. Leri A, Claudio PP, Li Q. et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local reninangiotensin system and decreases the Bcl-2-to- Bax protein ratio in the cell // J Clin Invest, 1998; 101(7): 1326.-134210.1172/JCI3165087109525975Search in Google Scholar

55. Loh YP, Cheng Y, Mahata SK et al. Chromogranin A and Derived Peptides in Health and Disease // J Mol Neurosc, 2012; 48: 347.-35610.1007/s12031-012-9728-2340261522388654Search in Google Scholar

56. MacNulty EE, Plevin R, Wakelam MJO. Stimulation of the hydrolysis of phosphatidylinositol 4,5-bisphosphate and phosphatidylcholine by endothelin, a complete mitogen for Rat-1 fibroblasts // Biochem J, 1990; 272: 761.-76610.1042/bj272076111497742176477Search in Google Scholar

57. Maisel A, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis of heart failure // N Engl J Med, 2002; 347 (3): 161-167Search in Google Scholar

58. Mann D. Pathophysiology of Heart Failure // Bonow RO, Mann DL, Zipes DP. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine/ 9th ed.- Philadelphia: Elsevier Saunders, 2012.- Pp. 487.-503Search in Google Scholar

59. Marron K, Wharton J, Sheppard MN et al. Distribution, Morphology, and Neurochemistry of Endocardial and Epicardial Nerve Terminal Arborizations in the Human Heart // Circulation, 1995; 92: 2343.-235110.1161/01.CIR.92.8.23437554220Search in Google Scholar

60. Molenaar P, Kuc RE, Davenport AP. Characterisation of two new ETB selective radioligands, [125I]- BQ3020 and [125I]-[Ala1,3,11,15] ET-1 in human heart // Brit J Pharmac, 1992; 107: 637.-63910.1111/j.1476-5381.1992.tb14498.x19077401472961Search in Google Scholar

61. Molenaar P, Oreilly G, Sharkey A. Characterisation and Localisation of Endotheli Receptor Subtypes in the Human Atrioventricular conducting System and Myocardium // Circ Res, 1993; 72(3): 526.-53810.1161/01.RES.72.3.526Search in Google Scholar

62. Mukoyama M, Nakao K, Hosada K et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide // J Clin Inves, 1991; 87: 1402.-141210.1172/JCI115146Search in Google Scholar

63. Nakagawa O, Ogawa Y, Itoh H et al. Rapid Transcriptional Activation and Early mRNA Turnover of Brain Natriuretic Peptide in Cardiocyte Hypertrophy // J Clin Inves, 1995; 96: 1280-1287Search in Google Scholar

64. Narula J, Haider N, Virmani R et al. Apoptosis in myocytes in end-stage heart failure // N Engl J Med, 1996; 335(16): 1182.-118910.1056/NEJM199610173351603Search in Google Scholar

65. Nichols M, Townsend N, Scarborough P et al. Cardiovascular disease in Europe 2014: epidemiological update // Eur Heart J, 2014; 35: 2950.-295910.1093/eurheartj/ehu299Search in Google Scholar

66. Nobels FRE, Kwekkeboom DJ, Bouillon R et al. Review. Chromogranin A: it`s clinical value as marker of neuroendocrine tumors // Eur J Clin Inves, 1998; 28: 431.-44010.1046/j.1365-2362.1998.00305.xSearch in Google Scholar

67. Noireaund J, Andiantsitohaina R. Recent Insights in the Paracrine Modulation of Cardiomyocyte Contractility by Cardiac Endothelial Cells // BioMed Research International, BioMed Research International, vol. 2014, Article ID 923805, 10 pages, 2014. doi:10.1155/2014/92380510.1155/2014/923805Search in Google Scholar

68. Ogawa Y, Nakao K, Nakagawa O et al. Human C-type natriuretic peptide. Characterization of the gene and peptide //Hypertension, 1992; 19(6): 809.-81310.1161/01.HYP.19.6.809Search in Google Scholar

69. Olivetti G, Quaini F, Lagrasta C et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart // J Mol Cell Cardiol, 1996; 28(9): 2005.-201610.1006/jmcc.1996.0193Search in Google Scholar

70. Olofsson B, Pajusala K, Kaipainen A et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells //Cell Biology, 1996; 93: 2576.-258110.1073/pnas.93.6.2576Search in Google Scholar

71. Park EJ, Chen HH, Winer J et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR // J Biol Chem, 1994; 269(41): 25646.-2565410.1016/S0021-9258(18)47298-5Search in Google Scholar

72. Pearlman JD, Hibberd MG, Chuang ML et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis // Nature Medicine, 1995; 1(10): 1085-1089 Search in Google Scholar

73. Pieroni M, Corti A, Tota B et al. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function // Eur Heart J, 2007; 28: 1117- 1127Search in Google Scholar

74. Pilmane M, Ozoliņa L, Ābola Z et al. Growth Factors, Their Receptors, Neuropeptide-Containing Innervation, and Matrix Metalloproteinases in the Proximal and Distal Ends of the Esophagus in Children With esophageal Atresia // Medicina, 2011; 47(8): 453-460Search in Google Scholar

75. Plumpton C, Champeney R, Ashby MJ et al. Characteriszation of Endothelin Isoforms in Human Heart: Endothelin-2 Demonstrated // J Cardiovasc Pharmac, 1993; 22(8): 26.-2810.1097/00005344-199322008-00009Search in Google Scholar

76. Pucci A, Wharton J, Arbustini E et al. Localization of brain and atrial natriuretic peptide in human and porcine heart // Int J Cardiol, 1992; 34: 237.-24710.1016/0167-5273(92)90020-4Search in Google Scholar

77. Rabkin SW. Review Article. Apoptosis in Human Acute Myocardial Infarction: The Rationale for Clinical Trials of Apoptosis Inhibition in Acute Myocardial Infarction // Scholarly Research Exchange, Volume 2009, Article ID 979318, http://dx.doi.org/10.3814/2009/979318 (10.06.2015)10.3814/2009/979318Search in Google Scholar

78. Rabkin SW, Kong JY. Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide // Am J Physiol Heart Circ Physiol, 2000; 279(6): 3089.-310010.1152/ajpheart.2000.279.6.H3089Search in Google Scholar

79. Rajamannan NM, Nealis T., Subramainiam M. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation // Circulation, 2005; 111(24): 3296.-330110.1161/CIRCULATIONAHA.104.473165Search in Google Scholar

80. Rajamannan NM, Subramainiam M, Rickard D et al. Human aortic valve calcification is associated with an osteoblast phenotype //Circulation, 2003; 107(17): 2181.-218410.1161/01.CIR.0000070591.21548.69Search in Google Scholar

81. Rechardt L, Aalto-Setala K, Purjeranta M et al. Peptidergic innervation of human arial myocardium: an electron microscopical and immunocytochemical study // J Auton Nerv Syst, 1986; 17: 21.-3210.1016/0165-1838(86)90041-XSearch in Google Scholar

82. Rosjo H, Masson S, Latini R et al. Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial // Eur J Heart Fail, 2010; 12: 549-556Search in Google Scholar

83. Saraste A, Pulkki K, Kallajoni M et al. Apoptosis in Human Acute Myocardial Infarction // Circulation, 1997; 95: 320.-32310.1161/01.CIR.95.2.3209008443Search in Google Scholar

84. Schaper J, Lorenz-Meyer S, Suzuki K The Role of Apoptosis in Dilated Cardiomyopathy // Herz, 1999; 24(3): 219.-22410.1007/BF0304496410412645Search in Google Scholar

85. Schirger JA, Heublein DM, Chen HH et al. Presence of Dendroaspis natriuretic peptidelike immunoreactivity in human plasma and its increase during human heart failure // Mayo Clinic Proceedings, 1999; 74(2): 126.-13010.4065/74.2.12610069348Search in Google Scholar

86. Shibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis // Genes and Cancer, 2011; 12(2): 1097.-110510.1177/1947601911423031Search in Google Scholar

87. Shubeita HE, McDonough PM, Harris AN et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy // J Biol Chem, 1990; 265 (33): 20555.-2056210.1016/S0021-9258(17)30538-0Search in Google Scholar

88. Sinagra G, Bussani R, Abbate A et al. Left Ventricular Diastolic Filling Pattern at Doppler Echocardiography and Apoptotic Rate in Fatal Acute Myocardial Infarction // Am J Cardiol, 2007; 99(3):307.-30910.1016/j.amjcard.2006.08.025Search in Google Scholar

89. Soni Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis // Human Pathology, 2003; 34(8): 756.-76310.1016/S0046-8177(03)00245-4Search in Google Scholar

90. Statistical data on population mortality // http://www.spkc.gov.lv/veselibas-aprupes-statistika/ (14.06.2015)Search in Google Scholar

91. Stewart DJ, Kubac G, Costello KB. Increased plasma endothelin-1 in the early hours of acute myocardial infarction // J Am Coll Cardiol, 1991; 18(1): 38.-4310.1016/S0735-1097(10)80214-1Search in Google Scholar

92. Suzuki Y, Suzuki H, Ohtake R et al. Changes in the plasma and urine alpha human atrial natriuretic peptide (alpha hANP) concentration in patients with thyroid disorders // Endocrinologia Japonica, 1988; 35(6): 907.-91310.1507/endocrj1954.35.907Search in Google Scholar

93. Syvaranta S, Helske S, Laine M. et al. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis // Arterioscler Thromb Vasc Biol, 2010; 30(6): 1220.-122710.1161/ATVBAHA.109.198267Search in Google Scholar

94. Takemura G, Fujiwara H, Mukoyama M. et al. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy // Circulation, 1991; 83(1): 181.-19010.1161/01.CIR.83.1.181Search in Google Scholar

95. Takemura G, Takatsu Y, Doyama K. et al. Expression of Atrial and Brain Natriuretic Peptides and their Genes in Hearts of Patients with Cardiac Amyloidosis // J Am Coll Cardiol, 1998; 31: 254.-26510.1016/S0735-1097(98)00045-XSearch in Google Scholar

96. Teerlink JR. Recent Heart Failure Trials of Neurohormonal Modulation (OVERTURE and ENABLE): Approaching the Asymtote of Efficacy? // J Card Fail, 2002; 8(3): 124Search in Google Scholar

97. Thompson RJ, Doran JF, Jackson P. Et al. PGP 9.5- a new marker for vertebrate neurons and neuroendocrine cells // Brain Research, 1983; 278: 224.-22810.1016/0006-8993(83)90241-XSearch in Google Scholar

98. Tomanek RJ, Zheng W, Yue X. Growth factor activation in myocardial vascularization: Therapeutic implications // Mol Cell Biol, 2004; 264: 3.-1110.1023/B:MCBI.0000044369.88528.a3Search in Google Scholar

99. Tota B, Cerra CM, Gattuso. Review. Catheholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of whip- brake system of the endocrine heart // J Exp Biol, 2010; 213: 3081.-3103 10.1242/jeb.027391Search in Google Scholar

100. Uusimaa P, Ruskoaho H, Vuolteenaho O. et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction // Int J Cardiol, 1999; 69: 5.-1410.1016/S0167-5273(99)00007-8Search in Google Scholar

101. Veinot JP, Gattinger DA, Fliss H. Early apoptosis in human myocardial infarcts // Hum Path, 1997; 28(4): 485.-49210.1016/S0046-8177(97)90039-3Search in Google Scholar

102. Vincenti V, Cassano C, Rocchi M et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 // Circulation, 1996; 93: 1493.-149510.1161/01.CIR.93.8.1493Search in Google Scholar

103. Vracko R, Thorning D, Frederickson RG. Nerve Fibers in Human Myocardial Scars // Hum Path, 1998; 22: 138.-146.10.1016/0046-8177(91)90035-NSearch in Google Scholar

104. Weiergraber M, Pereverzev A, Vajna R, Henry M. et al. Immunodetection of alpha1E voltage-gated Ca(2+) channel in chromogranin-positive muscle cells of rat heart, and in distal tubules of human kidney // J Histochem Cytochem, 2000; 48 (6): 807.-81910.1177/00221554000480060910820154Search in Google Scholar

105. Wharton J, Polak J, Gordon L. et al. Immunohistochemical Demonstration of Human Cardiac Innervation Before and After Transplantation // Circ Res, 1990; 66(4): 900.-912.10.1161/01.RES.66.4.9002317894Search in Google Scholar

106. Yanagisawa M, Kurihora H, Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells //Nature, 1988; 332:411.-41510.1038/332411a02451132Search in Google Scholar

107. Zeiher AM, Goebel H, Schachinger V et al. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina // Circulation, 1995; 91: 941.-94710.1161/01.CIR.91.4.941Search in Google Scholar

108. Zheng W, Seftor E, Meininger CJ. et al. Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta // Am J Physiol Heart Circ Physiol, 2001; 280: 909.-91710.1152/ajpheart.2001.280.2.H90911158993Search in Google Scholar

109. Zolk O, Böhm M. The role of the cardiac endothelin system in heart failure // Nephrol Dial Transplant, 2000; 15 (6): 758-760Search in Google Scholar